Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zometa for Pain and QoL in Cancer Patients with Bone Lesions
NCT00029224Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2001
- Primary completion
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in bone metastases, sponsored by Novartis. Started Oct 2001; status: completed.
02
Drugs
zoledronic acid
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT00029224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00029224.